LuciBriga (Brigatinib) 90mg/180mg*30's | Generic ALK Inhibitor Laos | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Делиться
Product description

Generic Information: LuciBriga (Laos)

LuciBriga is a Lao-manufactured generic of brigatinib, produced by Lucius Pharmaceuticals. It is available in 90 mg and 180 mg strengths, each in a 30-tablet pack, which mirrors the two dosing steps of the standard brigatinib schedule. As a generic second-generation ALK inhibitor, LuciBriga offers the same active ingredient as the originator at a lower, out-of-pocket-friendly price.

What Is LuciBriga Used For?

LuciBriga is used for the first-line and post-crizotinib treatment of anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer. The two strengths let a patient start at 90 mg once daily and then escalate to 180 mg once daily, all with the same brand. A genetic test confirming the ALK rearrangement is required before prescribing.

How Does LuciBriga (Brigatinib) Work?

The brigatinib in LuciBriga is a next-generation ALK tyrosine kinase inhibitor that also targets ROS1, IGF-1R, and FLT-3. It blocks ALK-driven growth signaling and crosses the blood-brain barrier, making it effective against brain metastases. Because the generic delivers the same pharmacology as the originator, it can serve as a cost-saving substitute for the branded drug.

Indications

LuciBriga is indicated for adults with ALK-positive, locally advanced or metastatic NSCLC, both as initial therapy and after progression on crizotinib. It is not suitable for ALK-negative tumors and is not indicated for small-cell lung cancer.

Dosage

The recommended regimen begins with 90 mg once daily for 7 days, increasing to 180 mg once daily if tolerated. Take the tablet with or without food, at the same time each day, and swallow it whole. If a dose is missed or vomiting occurs, do not take an extra tablet — continue with the next scheduled dose. A treatment gap of 14 days or more requires a fresh 7-day 90 mg lead-in.

Side Effects

Common side effects include diarrhea, rash, cough, hypertension, fatigue, nausea, muscle pain, and headache. Blood pressure should be monitored, and diarrhea is generally manageable with supportive care. Interstitial lung disease is rare but serious, and treatment must be stopped permanently if it is confirmed.

Storage

Keep LuciBriga below 30°C in a dry place, in the original packaging, and away from children. No cold storage is required.

Why Choose the GLT?

For patients paying out of pocket, a Lao generic such as LuciBriga provides a meaningful cost advantage over the originator brand. The originator's Western list price is very high, while Lao generic brigatinib is priced far more affordably, making long-term daily therapy more financially sustainable. GLT sources from verified manufacturers and helps with the documentation needed for import.

How to Order

To order LuciBriga through GLT, message us on WhatsApp at +86 15234153837 or email [email protected]. Let us know whether you need 90 mg or 180 mg, the number of boxes, and your destination, and we will confirm availability, sourcing, and shipping terms.

FAQ

Is LuciBriga the same as Alunbrig? LuciBriga is a generic of brigatinib, the same active ingredient as Alunbrig, but produced by Lucius Pharmaceuticals in Laos. The pharmacology is equivalent, while the price is lower.

What strengths does LuciBriga come in? LuciBriga is available in 90 mg and 180 mg tablets, each in a 30-tablet pack, covering the lead-in and maintenance steps of the dosing schedule.

Where can I buy generic brigatinib? Generic brigatinib can be sourced through international suppliers such as GLT. Always verify the supplier and request proper documentation before purchasing.

Related Oncology Products

Орфорглипрон (LuciOrfor) 0,8–17,2 мг таблетки | Лаосский дженерик пероральный GLP-1 | GLT

Дженерик орфорглипрона от Lucius Pharmaceuticals (Лаос), 6-ступенчатая схема титрования для контроля веса

AVATODX (Аватромбопаг) 20мг*30 таб. | Bigbear Pharmaceutical (Лаос) | GLT

AVATODX — аватромбопаг 20 мг от Bigbear Pharmaceutical (Lao) Co., Ltd., лаосский рег. № 06L0985/23,...

Орфорглипрон (OriYo) 0,8–17,2 мг таблетки | Бангладешский дженерик пероральный GLP-1 | GLT

Дженерик орфорглипрона от National Drug Co. (Бангладеш), 6-ступенчатая титрация для контроля веса

Olumiant (Барицитиниб) таблетки 2мг/4мг | Ингибитор JAK1/JAK2 | Eli Lilly (США) | GLT

Селективный ингибитор JAK1/JAK2 компании Eli Lilly для лечения ревматоидного артрита, атопического дерматита и тяжёлой очаговой...

Avabopa (Аватромбопаг) 20 мг × 30 таблеток | Tongmeng TLPH Лаос | GLT

Avabopa — аватромбопаг 20 мг от Tongmeng (Lao) Pharmaceutical and Food Co., Ltd. (TLPH), регистрация...

Barinib (Барицитиниб) 2мг | Дженерик-ингибитор JAK1/JAK2 | Drug International Limited | GLT

Дженерик барицитиниба (ингибитора JAK1/JAK2) от Drug International Limited (Бангладеш) — доступная альтернатива Olumiant при ревматоидном...

SPINRAZA (Нусинерсен) 12 мг/5 мл | Покупка из Китая | Терапия СМА | GLT

Первый в своём классе антисмысловой олигонуклеотид Biogen для лечения СМА, одобренный NMPA и возмещаемый в...

Tirzema (Тирзепатид) 2,5/5/7,5мг/0,5мл одноразовая шприц-ручка | Incepta (Бангладеш) | GLT

Tirzema — одноразовая шприц-ручка тирзепатида Incepta Pharmaceuticals, три официальные дозировки (2,5/5/7,5мг/0,5мл) для СД2 и контроля...